Rhenman & Partners Asset Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Rhenman & Partners Asset Management’s Portfolio PHAT Stock Details PHAT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$2.64M	Hold
2022 Q3	$2.49M	Hold
2022 Q2	$1.99M	Hold
2022 Q1	$3.2M	Buy
2021 Q4	$3.62M	Hold
2021 Q3	$5.98M	Hold
2021 Q2	$6.3M	Buy
2021 Q1	$6.57M	Hold
2020 Q4	$5.81M	Buy